Hana Biosciences, Inc. Announces Positive Results Of Initial Registration Trial With Zensana(TM), First Ondansetron Oral Spray For Chemotherapy-Induced Nausea And Vomiting

Results of pivotal study demonstrate Zensana(TM) (ondansetron oral spray) 8 mg dose is statistically bioequivalent to the current commercially available 8 mg ondansetron (Zofran(R)) tablet.